Form 4 for INGN Inogen Inc
Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001209191-22-048923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-06 | 2022-09-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | M - OptEx | $0.00 | +3,685 | 21.2K | +21% | $0 |
| D | 2022-09-06 | 2022-09-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | F - Tax | $28.78 | -1,828 | 19.4K | -9% | -$52.6K |
| DM | 2022-09-06 | 2022-09-01 | INGN | Shabshab Nabil | CEO, Pres, Dir | M - OptEx | $0.00 | -3,685 | 12.7K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-01 | M | A | 3,685 | $0.00 | 21,197 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-01 | F | D | 1,828 | $28.78 | 19,369 | D | — | — | (F1) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022. |
| 3 | Derivative | Restricted Stock Unit | 2022-09-01 | M | D | 1,568 | $0.00 | 10,978 | D | — · — to — | 1,568 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F3) Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. |
| 4 | Derivative | Restricted Stock Unit | 2022-09-01 | M | D | 2,117 | $0.00 | 12,702 | D | — · — to — | 2,117 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F4) Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. |